| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix
|
CHAN, K.K.L.
|
|
|
18 |
3 |
p. 559-563
|
artikel
|
| 2 |
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer
|
WRIGHT, J.D.
|
|
|
18 |
3 |
p. 400-406
|
artikel
|
| 3 |
An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model
|
PIETERSE, Q.D.
|
|
|
18 |
3 |
p. 432-438
|
artikel
|
| 4 |
A randomized study of screening for ovarian cancer: a multicenter study in Japan
|
KOBAYASHI, H.
|
|
|
18 |
3 |
p. 414-420
|
artikel
|
| 5 |
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
|
SALANI, R.
|
|
|
18 |
3 |
p. 487-491
|
artikel
|
| 6 |
Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
|
PAUTIER, P.
|
|
|
18 |
3 |
p. 446-452
|
artikel
|
| 7 |
Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study
|
TETSCHE, M.S.
|
|
|
18 |
3 |
p. 421-427
|
artikel
|
| 8 |
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
|
STRAUSS, H.-G.
|
|
|
18 |
3 |
p. 515-524
|
artikel
|
| 9 |
Erratum
|
de Wiel, Van
|
|
|
18 |
3 |
p. 590
|
artikel
|
| 10 |
Expression of CD133–1 and CD133–2 in ovarian cancer
|
FERRANDINA, G.
|
|
|
18 |
3 |
p. 506-514
|
artikel
|
| 11 |
Expression of hypoxia-inducible factor 1a gene affects the outcome in patients with ovarian cancer
|
SHIMOGAI, R.
|
|
|
18 |
3 |
p. 499-505
|
artikel
|
| 12 |
Extracellular regulated kinase-2 immunoreactivity increases in parallel with cervical intraepithelial neoplasia grade in cervical neoplasia
|
KAPETANIOS, V.
|
|
|
18 |
3 |
p. 540-545
|
artikel
|
| 13 |
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
|
LEISEROWITZ, G.S.
|
|
|
18 |
3 |
p. 470-475
|
artikel
|
| 14 |
High dose single-agent paclitaxel in a hemodialysis patient with advanced ovarian cancer: a case report with pharmacokinetic analysis and review of the literature
|
BAUR, M.
|
|
|
18 |
3 |
p. 564-570
|
artikel
|
| 15 |
Immunization of mice with plasmids coexpressing HPV16 E5 and the novel oncogene hWAPL
|
CAO, C.X.
|
|
|
18 |
3 |
p. 534-539
|
artikel
|
| 16 |
Laparoscopic ovarian transposition in patients with early cervical cancer
|
PAHISA, J.
|
|
|
18 |
3 |
p. 584-589
|
artikel
|
| 17 |
Laparoscopy versus laparotomy for benign ovarian tumor: a systematic review and meta-analysis
|
MEDEIROS, L.R.
|
|
|
18 |
3 |
p. 387-399
|
artikel
|
| 18 |
Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy
|
RAMIREZ, P.T.
|
|
|
18 |
3 |
p. 571-575
|
artikel
|
| 19 |
Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening
|
YEMELYANOVA, A.V.
|
|
|
18 |
3 |
p. 465-469
|
artikel
|
| 20 |
Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent
|
NARAYAN, K.
|
|
|
18 |
3 |
p. 525-533
|
artikel
|
| 21 |
Pelvic ganglioneuroma
|
GUZIN, K.
|
|
|
18 |
3 |
p. 553-556
|
artikel
|
| 22 |
Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases and review of the literature
|
HORST, C.V.A.N.D.E.R.
|
|
|
18 |
3 |
p. 549-553
|
artikel
|
| 23 |
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study
|
KAVANAGH, J.J.
|
|
|
18 |
3 |
p. 460-464
|
artikel
|
| 24 |
Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo
|
SU, M.
|
|
|
18 |
3 |
p. 476-486
|
artikel
|
| 25 |
Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period
|
ÄKESON, M.
|
|
|
18 |
3 |
p. 453-459
|
artikel
|
| 26 |
Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series
|
KWON, J.S.
|
|
|
18 |
3 |
p. 546-549
|
artikel
|
| 27 |
Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer
|
LE, T.
|
|
|
18 |
3 |
p. 428-431
|
artikel
|
| 28 |
Radiotherapy in congenital vulvar lymphangioma circumscriptum
|
YILDIZ, F.
|
|
|
18 |
3 |
p. 556-559
|
artikel
|
| 29 |
Significance of E2F-1 overexpression in epithelial ovarian cancer
|
SUH, D.S.
|
|
|
18 |
3 |
p. 492-498
|
artikel
|
| 30 |
The influence of reproductive and hormonal factors on ovarian cancer survival
|
NAGLE, C.M.
|
|
|
18 |
3 |
p. 407-413
|
artikel
|
| 31 |
The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey
|
MOSS, E.L.
|
|
|
18 |
3 |
p. 439-445
|
artikel
|
| 32 |
Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report
|
PIETERSE, Q.D.
|
|
|
18 |
3 |
p. 576-583
|
artikel
|
Tijdschrift beschrijving